Difficulty: Medium
Average Score: 86%
Practice
Which drug is used for alcohol withdrawal and seizure management but induces metabolism of warfarin and phenytoin?
Correct answer
C
Rationale
The correct answer is C) Phenobarbital. Phenobarbital is used for alcohol withdrawal and seizure management due to its potent anticonvulsant and sedative-hypnotic properties. However, it is important to note that Phenobarbital induces the metabolism of drugs such as warfarin and phenytoin by increasing the activity of liver enzymes responsible for their breakdown. This can lead to decreased levels of warfarin and phenytoin in the body, potentially reducing their effectiveness.
A) Chlordiazepoxide is also used for alcohol withdrawal, but it does not induce the metabolism of warfarin and phenytoin. It acts by enhancing the activity of gamma-aminobutyric acid (GABA) receptors in the brain.
B) Meprobamate is a sedative-hypnotic drug used for anxiety and tension, but it is not commonly used for alcohol withdrawal or seizure management. It does not induce the metabolism of warfarin and phenytoin.
D) Triazolam is a short-acting benzodiazepine primarily used for the treatment of insomnia. It does not have a significant role in alcohol withdrawal or seizure management and does not induce the metabolism of warfarin and phenytoin.
Educationally, understanding the interactions of drugs like Phenobarbital with other medications is crucial for healthcare professionals to ensure safe and effective treatment for patients. It highlights the importance of considering potential drug-drug interactions when prescribing multiple medications to a patient, especially those with complex medical conditions like alcohol withdrawal and seizures.
A) Chlordiazepoxide is also used for alcohol withdrawal, but it does not induce the metabolism of warfarin and phenytoin. It acts by enhancing the activity of gamma-aminobutyric acid (GABA) receptors in the brain.
B) Meprobamate is a sedative-hypnotic drug used for anxiety and tension, but it is not commonly used for alcohol withdrawal or seizure management. It does not induce the metabolism of warfarin and phenytoin.
D) Triazolam is a short-acting benzodiazepine primarily used for the treatment of insomnia. It does not have a significant role in alcohol withdrawal or seizure management and does not induce the metabolism of warfarin and phenytoin.
Educationally, understanding the interactions of drugs like Phenobarbital with other medications is crucial for healthcare professionals to ensure safe and effective treatment for patients. It highlights the importance of considering potential drug-drug interactions when prescribing multiple medications to a patient, especially those with complex medical conditions like alcohol withdrawal and seizures.